Boehringer Ingelheim Venture Fund

Advent France Biotechnology launches its second fund with a first close at €86M ($102M)

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the first closing of its second fund for a total of €86M ($102M). The European Investment […]

September 30, 2021September 30, 2021 Newsroom Business, Finances, Start Up

by The Network expands its creative footprint with signings of new agencies

San Francisco Bay Coffee and Cutwater brew up animated, eco-friendly campaign

Epica Awards announced 2024 winners

Maison Hennessy and OK C’Est Cool, behind Hennessy X.O Collection by Florian Zumbrunn

Euromonitor: Chocolate boxes and toys, on top of the list this Christmas

Microsoft’s Austin Scott joins Bedrock Platform as chief commercial officer

Tag: Boehringer Ingelheim Venture Fund

Advent France Biotechnology launches its second fund with a first close at €86M ($102M)